Quantum-Si Shares Slip After Next-Gen Proteomics Platforms Are Unveiled
Quantum-Si Shares Slip After Next-Gen Proteomics Platforms Are Unveiled
On the other hand, Quantum-Si will launch Proteus in the second half of 2026.Quantum-Si Inc (NASDAQ:QSI) shares tanked over 12.8% Thursday morning.
周四上午，量子硅公司（纳斯达克股票代码：QSI）股价下跌了12.8％以上。
The company plans to introduce Platinum Pro, an advanced version of its Platinum platform, in the first half of 2025. Platinum Pro will feature a streamlined workflow, reducing hands-on time and speeding up processing.
该公司计划在2025年上半年推出其铂金平台的高级版本Platinum Pro。Platinum Pro 将采用简化的工作流程，减少动手时间并加快处理速度。
It will support both local and cloud-based data analysis, and introduce a 'Pro Mode' for custom application development, offering a valuable tool for biopharmaceutical clients.
它将支持本地和基于云的数据分析，并为自定义应用程序开发引入 “专业模式”，为生物制药客户提供有价值的工具。
On the other hand, Quantum-Si will launch Proteus in the second half of 2026.
另一方面，量子硅将在2026年下半年推出Proteus。
Proteus is expected to offer advanced capabilities, including ultrasensitive detection of proteoforms, unbiased analysis of complex samples, and a new rapid sequencing chemistry that reduces run time to 90 minutes or less.
预计Proteus将提供先进的功能，包括对蛋白质的超灵敏检测、对复杂样本的无偏分析以及可将运行时间缩短至90分钟或更短的新型快速测序化学成分。
The company expects Proteus to serve as the foundational platform for scaling sequencing output, progressing from tens of millions of reads per sample at launch to billions over time.
该公司预计，Proteus将成为扩大测序输出的基础平台，随着时间的推移，每个样本的读取量将从发射时的数千万次增加到数十亿次。
CEO Jeff Hawkins expects Proteus to "open broad new markets for diverse applications in protein analysis, driving increased revenue growth that will create significant value for our shareholders."
首席执行官杰夫·霍金斯预计，Proteus将 “为蛋白质分析的各种应用开辟广阔的新市场，推动收入增长，这将为我们的股东创造可观的价值。”
"With these technology advancements and partnerships in place, we believe we will be able to further extend our leadership position in next-generation protein sequencing while also extending into other areas of proteomics more generally."
“有了这些技术进步和合作伙伴关系，我们相信我们将能够进一步扩大我们在下一代蛋白质测序中的领导地位，同时还能更广泛地扩展到蛋白质组学的其他领域。”
To accelerate the development of Proteus and mitigate risks in the hardware platform delivery, Quantum-Si recently announced new partnerships and collaborations.
为了加快Proteus的开发并降低硬件平台交付中的风险，Quantum-Si最近宣布了新的合作伙伴关系和合作。
Yesterday, Quantum-Si announced a collaboration with Nvidia to develop its new proteomics platform.
昨天，Quantum-Si宣布与英伟达合作开发其新的蛋白质组学平台。
Also, the company entered into a distribution agreement with Avantor, as per which, Avantor will distribute Quantum-Si's Next-Generation Protein Sequencing (NGPS) portfolio in the U.S. and Canada, offering researchers across various market segments easier access to these innovative proteomics solutions.
此外，该公司还与Avantor签订了分销协议，根据该协议，Avantor将在美国和加拿大分销Quantum-Si的下一代蛋白质测序（NGPS）产品组合，使各个细分市场的研究人员更容易获得这些创新的蛋白质组学解决方案。
Price Action: Quantum-Si shares are down 12.88% at last check Thursday, trading around $1.21 a share.
价格走势：量子硅股价在周四的最后一次检查中下跌了12.88％，交易价格约为每股1.21美元。
Read Next:
继续阅读：
- Uber Could Pick Up $10M Stake In Chinese Autonomous Driving Firm Pony AI's US IPO: Report
- 报告称，优步可能收购中国自动驾驶公司Pony AI在美国的首次公开募股的1000万美元股份
Image via Quantum-Si
图片来自 Quantum-Si
